LOGIN  |  REGISTER

Mobile-health Network Solutions (NASDAQ: MNDR) Stock Quote

Last Trade: US$ 2.27
Volume: 1,420,697
5-Day Change: 0%
YTD Change: 0%
Market Cap: -

Latest News From Mobile-health Network Solutions

SINGAPORE, May 10, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) (“MaNaDr” or “the Company”), a leading Asia-Pacific telehealth provider, today announced the establishment of a subsidiary in Malaysia. This strategic expansion signifies MNDR's commitment to delivering accessible and affordable healthcare services throughout Southeast Asia. Solidifying Regional Leadership The Malaysian subsidiary... Read More
SINGAPORE, May 06, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) (“MaNaDr” or “the Company”), a leading Asia-Pacific telehealth provider, today addresses the recent market fluctuations in its share price. The full message from the Co-Founders, Dr Siaw Tung Yeng and Dr Rachel Teoh Pui Pui is as follows: Dear Valued Shareholders, Investors, Employees, and Partners, We are writing to you today to... Read More
SINGAPORE, April 30, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) (“MaNaDr” or “the Company”), a leading Asia-Pacific telehealth provider, today announced the grand opening of ManaPharma Pharmacy, the Company’s new retail pharmacy, at 12 noon local time. Conveniently located near the central business and shopping areas of Singapore, ManaPharma Pharmacy offers a wide selection of affordably priced... Read More
SINGAPORE, April 23, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) (“MaNaDr” or the “Company”), a pioneering Asia-Pacific (“APAC”) telehealth provider, has announced a strategic partnership with PT Indopasifik Teknologi Medika Indonesia, better known as Lifepack, an online prescription provider based in Indonesia. The collaboration aims to improve healthcare accessibility in Indonesia by bringing... Read More
SINGAPORE, April 22, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR ) (“ Mobile-Health ” or the “ Company ”), a pioneering Asia-Pacific (“APAC”) telehealth provider, today provided financial guidance for our anticipated results on our six months ended December 31, 2023 (“ H12024 ”). The Company continues to experience tremendous demand for its telemedicine services. The average monthly telemedicine... Read More
SINGAPORE, April 17, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR ), a leading telehealth solutions provider in Singapore, today announced that the Company has been ranked number 41 in the Financial Times annual listing of 500 high-growth Asia-Pacific companies. The listing , published March 13, was based on the company’s revenue growth between 2019 and 2022. During this period, MaNaDr Pte Ltd, a... Read More
SINGAPORE, April 15, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR ), a pioneering Asia-Pacific (APAC) telehealth provider, celebrates its successful initial public offering (IPO) on the Nasdaq stock exchange. This achievement marks MNDR as the first pure-play telehealth company from APAC to list on a major US stock exchange. “This IPO is a significant achievement for MNDR and reflects the surging... Read More
SINGAPORE, April 12, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (“MNDR ” or “the Company ”), a leading telehealth solutions provider in Singapore, today announced the closing of its previously announced initial public offering of an aggregate 2,250,000 Class A Ordinary Shares ( “the Offering ”) at a price of $4.00 per share ( “the Offering Price ”) to the public, for a total of US$9.0 million of gross proceeds... Read More
Singapore, April 09, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (“ MNDR ” or the “ Company ”), a leading telehealth solutions provider in Singapore, today announced the pricing of its firm commitment initial public offering of an aggregate 2,250,000 Class A Ordinary Shares (the “ Offering ”). The Offering is priced at $4.00 per share (the “ Offering Price ”). The Company has granted the underwriter a 45-day... Read More
C4 Therapeutics

COPYRIGHT ©2023 HEALTH STOCKS HUB